Update: Common anticholinergic meds seen to increase dementia risk
________________
Dear reader,
It’s time for SharpBrains e-newsletter discussing the latest research and innovations to help promote brain health, opening in this occasion with a large and worrying study tracking the long-term neural impact of commonly prescribed medications.
New brain research:
First, do no harm? Common anticholinergic meds seen to increase dementia risk
…which is one of the many reasons why these 10 highlights from the 2019 SharpBrains Virtual Summit are so important to shape a better system and future
New study reinforces the importance of walking through forests for mental and general health
AARP: A majority of Americans believe dietary supplements improve brain health, despite the lack of evidence
New brain technology:
The Ontario Brain Institute (OBI) announces six new ONtrepreneurs working at the frontier of applied neurotech
Monitoring the body’s electrical signalling to enhance brain health
Few wearable neurotechnologies have been directly tested by high-quality, peer-reviewed research
New brain thinking:
Watch all Recordings from the 2019 SharpBrains Virtual Summit
July 9th in Toronto, Canada: Latest research findings on Neuroplasticity and Neuropsychology
Kindle Countdown Deal to read over the summer (and apply!) a great book on brain health and neuro-fitness
People spent $1.9 billion last year on apps to keep their brains sharp as they age — here’s what actually works
Last but not least, here is a fun brain teaser ...
Source: SharpBrains - Category: Neuroscience Authors: SharpBrains Tags: Brain Teasers Cognitive Neuroscience Technology anticholinergic anticholinergic drugs brain health Brain-Fitness brain-teaser dementia dementia risk neural impact neurofitness neuroplasticity Neuropsychology neurotechnologies Source Type: blogs
More News: Brain | Canada Health | Complementary Medicine | Dementia | Diets | Men | Neurology | Neuroscience | Nutrition | Study